While aberrant ZMIZ2 expression has related to several cancer types, such as prostate cancer [13], breast cancer [18] and colorectal cancer [19], its potential involvement in HCC remains unclear. This evidence concerns the gene ZMIZ2 and hepatocellular carcinoma.